Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival.

Sci Rep

Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, 646000, Sichuan, PR China.

Published: January 2019

AI Article Synopsis

  • Histone methylation influences gene regulation, with abnormalities linked to cancer; JMJD3 is a demethylase that plays a context-specific role in tumor development.
  • This study investigates JMJD3's expression in gastric cancer, revealing that high levels correlate with poor patient survival and serve as an independent prognostic indicator.
  • Findings suggest that genetic mutations and DNA methylation contribute to JMJD3 deregulation, highlighting its potential as a therapeutic target, with inhibitors like GSK-J4 showing promise in countering its oncogenic effects.

Article Abstract

Histone methylation is thought to control the regulation of genetic program and the dysregulation of it has been found to be closely associated with cancer. JMJD3 has been identified as an H3K27 demethylase and its role in cancer development is context specific. The role of JMJD3 in gastric cancer (GC) has not been examined. In this study, JMJD3 expression was determined. The prognostic significance of JMJD3 and its association with clinical parameters were evaluated. JMJD3 dysregulation mechanism and targets were analyzed. The effect of JMJD3 mutation was determined by functional study. Results showed that JMJD3 was overexpressed in different patient cohorts and also by bioinformatics analysis. High JMJD3 expression was correlated with shortened overall survival in patients with GC and was an independent prognosis predictor. Genetic aberration and DNA methylation might be involved in the deregulation of JMJD3 in GC. Downstream network of JMJD3 was analyzed and several novel potential targets were identified. Furthermore, functional study discovered that both demethylase-dependent and demethylase-independent mechanisms were involved in the oncogenic role of JMJD3 in GC. Importantly, histone demethylase inhibitor GSK-J4 could reverse the oncogenic effect of JMJD3 overexpression. In conclusion, our study report the oncogenic role of JMJD3 in GC for the first time. JMJD3 might serve as an important epigenetic therapeutic target and/or prognostic predictor in GC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351656PMC
http://dx.doi.org/10.1038/s41598-018-37340-wDOI Listing

Publication Analysis

Top Keywords

jmjd3
15
role jmjd3
12
jmjd3 gastric
8
gastric cancer
8
study jmjd3
8
jmjd3 expression
8
functional study
8
oncogenic role
8
comprehensive profiling
4
profiling jmjd3
4

Similar Publications

JMJD3 deficiency disturbs dopamine biosynthesis in midbrain and aggravates chronic inflammatory pain.

Acta Neuropathol Commun

December 2024

Laboratory of Stem Cell Biology and Epigenetics, School of Basic Medical Sciences, Shanghai University of Medicine & Health Sciences, 279 Zhouzhu Highway, Pudong New Area, Shanghai, 201318, China.

Midbrain dopamine (mDA) neurons participate in a wide range of brain functions through an intricate regulation of DA biosynthesis. The epigenetic factors and mechanisms in this process are not well understood. Here we report that histone demethylase JMJD3 is a critical regulator for DA biosynthesis in adult mouse mDA neurons.

View Article and Find Full Text PDF

Cerebral ischemic stroke ranks among the leading causes of death and disability worldwide. A significant challenge, beyond the lack of effective therapies, is the frequent oversight of sex as a vital factor in stroke research. This study focuses on elucidating the sex-specific epigenetic mechanisms that contribute to neural damage and recovery in cerebral ischemia.

View Article and Find Full Text PDF
Article Synopsis
  • The research aims to explore how the JMJD3-IRF4 signaling pathway affects macrophage polarization and the aggressive behavior of multiple myeloma (MM) cells.
  • The study involves differentiating THP-1 monocytes into various macrophage groups and examining changes in specific protein levels and cell behaviors like proliferation, apoptosis, migration, and invasion.
  • Results show that M2 macrophages stimulated proliferation and clone formation of MM cells while increasing specific markers (like CD206 and Arg-1) and cytokines (IL-10 and TGF-β), indicating that this polarization plays a significant role in MM malignancy.
View Article and Find Full Text PDF

Dysregulated RNA metabolism caused by SMN deficiency leads to motor neuron disease spinal muscular atrophy (SMA). Current therapies improve patient outcomes but achieve no definite cure, prompting renewed efforts to better understand disease mechanisms. The calcium channel blocker flunarizine improves motor function in -deficient mice and can help uncover neuroprotective pathways.

View Article and Find Full Text PDF

Emerging role of Jumonji domain-containing protein D3 in inflammatory diseases.

J Pharm Anal

September 2024

State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang, 315211, China.

Jumonji domain-containing protein D3 (JMJD3) is a 2-oxoglutarate-dependent dioxygenase that specifically removes transcriptional repression marks di- and tri-methylated groups from lysine 27 on histone 3 (H3K27me2/3). The erasure of these marks leads to the activation of some associated genes, thereby influencing various biological processes, such as development, differentiation, and immune response. However, comprehensive descriptions regarding the relationship between JMJD3 and inflammation are lacking.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!